Udaipur to manufacture performing corrosive chemistries
Macsen Labs Group says its new Active Pharmaceutical Ingredient (API) manufacturing facility in Udaipur, Rajasthan, represents a major advancement in their dedication to improving manufacturing capacities to meet the increasing demands of the pharmaceutical sector.
It has commenced construction of the facility on a 25,000 sq m site near one of its existing units, Macsen Drugs in RIICO Industrial Area, Gudli, Udaipur https://www.makeinindia.com/home/.
The new facility is five times larger in land area compared to the current infrastructure at Macsen Drugs, which is a USFDA inspected, TGA-GMP, and WHO-GMP certified manufacturing unit, said the Udaipur-headquartered manufacturer https://fieo.org/.
Designed to support scalability and operational efficiency, the new facility will include multiple API production blocks capable of handling diverse and advanced manufacturing processes for APIs for various therapeutic applications https://www.bseindia.com/.
Macsen plans to invest approximately Rs.75 crore in the initial phase of development, which will include two multistorey API Production Blocks equipped with cutting-edge technology and a combined reactor capacity of 100 KL (both stainless steel & glass-lined reactors); a new dedicated state-of-the-art R&D center over an area of 15,000 sq ft; an advanced Pilot Plant equipped with comprehensive process equipment and technologies, which will enable pilot-scale production of APIs and commercial production of low-volume, pre-clinical and clinical trial APIs https://www.nseindia.com/.
“We also have the plan to install a special production line for manufacturing & performing corrosive chemistries with Hastelloy, Halar-coated equipment, etc.,” said Achal Agrawal, Chairman and CEO of Macsen Group https://sbi.com.in/.
Announcing the facility construction on 6 Jan, he elaborated, “We aim to commence production activities at this new facility by the end of 2025. This expansion underscores our long-term vision to strengthen our manufacturing footprint and enhance our capacity to deliver high-quality, cost-effective pharmaceutical solutions to the global market.”
Macsen Labs (N.K Agrawal Group), a chemical manufacturing organization with its origin dating back to 1952, is engaged in manufacturing of Niche Active Pharmaceutical Ingredients (APIs), pharmaceutical application dyes, compounds of precious and rare earth metals, and other specialty inorganic compounds. Fiinews.com
